Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Oger

Showing results (91-100 of 127) with videos related to

Pageof 13
Sort By:
Cellular Immunology|August 15, 1980
Reduced T-lymphocyte cell reactivity as a function of human agingJ P Antel, J J Oger, E Dropcho, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 25, 2002
Baló's concentric sclerosis: surviving normal myelin in a patient with a relapsing-remitting dinical courseG R Moore, K Berry, J J Oger, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 24, 1999
Treatment with interferon beta-1b improves quality of life in multiple sclerosisG P Rice, J Oger, P Duquette, et al.
Neurology|December 1, 1991
Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. II. Immunologic evaluationL F Kastrukoff, J J Oger, W W Tourtellotte, et al.
Annals of Neurology|August 1, 1984
Low T8 antigen density on lymphocytes in active multiple sclerosisA T Reder, J P Antel, J J Oger, et al.
Annals of Neurology|January 1, 1994
Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosisD W Paty, D K Li, J J Oger, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 5, 1999
An apparent case of human T-cell lymphotropic virus type II (HTLV-II)-associated neurological disease: a clinical, molecular, and phylogenetic characterisationA A Peters, J J Oger, M B Coulthart, et al.
Cellular Immunology|December 1, 1982
Age-related changes in in vitro immunoglobulin secretion: comparison of responses to T-dependent and T-independent polyclonal activatorsL G Wrabetz, J P Antel, J J Oger, et al.
The Journal of Cell Biology|March 1, 1977
Secretion of nerve growth factor by central nervous system glioma cells in cultureR A Murphy, J Oger, J D Saide, et al.
Journal of the Neurological Sciences|September 30, 2008
Longitudinal changes in myelin water fraction in two MS patients with active diseaseI M Vavasour, C Laule, D K B Li, et al.
Pageof 13

Showing results (91-100 of 127) with videos related to

Sort By:
Pageof 13
Cellular Immunology|August 15, 1980
Reduced T-lymphocyte cell reactivity as a function of human agingJ P Antel, J J Oger, E Dropcho, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 25, 2002
Baló's concentric sclerosis: surviving normal myelin in a patient with a relapsing-remitting dinical courseG R Moore, K Berry, J J Oger, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 24, 1999
Treatment with interferon beta-1b improves quality of life in multiple sclerosisG P Rice, J Oger, P Duquette, et al.
Neurology|December 1, 1991
Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. II. Immunologic evaluationL F Kastrukoff, J J Oger, W W Tourtellotte, et al.
Annals of Neurology|August 1, 1984
Low T8 antigen density on lymphocytes in active multiple sclerosisA T Reder, J P Antel, J J Oger, et al.
Annals of Neurology|January 1, 1994
Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosisD W Paty, D K Li, J J Oger, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 5, 1999
An apparent case of human T-cell lymphotropic virus type II (HTLV-II)-associated neurological disease: a clinical, molecular, and phylogenetic characterisationA A Peters, J J Oger, M B Coulthart, et al.
Cellular Immunology|December 1, 1982
Age-related changes in in vitro immunoglobulin secretion: comparison of responses to T-dependent and T-independent polyclonal activatorsL G Wrabetz, J P Antel, J J Oger, et al.
The Journal of Cell Biology|March 1, 1977
Secretion of nerve growth factor by central nervous system glioma cells in cultureR A Murphy, J Oger, J D Saide, et al.
Journal of the Neurological Sciences|September 30, 2008
Longitudinal changes in myelin water fraction in two MS patients with active diseaseI M Vavasour, C Laule, D K B Li, et al.
Pageof 13